DEA
- CAS No.
- 150314-35-5
- Chemical Name:
- DEA
- Synonyms
- DOCOSATETRAENYLETHANOLAMIDE;DOCOSATETRAENOYL ETHANOLAMIDE;7,10,13,16-Dtea;7,10,13,16-docosatetraenylethanolamide;7,10,13,16-Docosatetraenoylethanolamine;(all-Z)-N-(7,10,13,16-Docosatetraenoyl)ethanolamine;Anandamide (22:4, n-6) (Docosatetraenylethanolamide);N-(2-HYDROXYETHYL)-7Z, 10Z, 13Z, 16Z-DOCOSATETRAENAMIDE;N-(2-Hydroxyethyl)-7,10,13,16-docosatetraenamide (all-Z)-;7,10,13,16-Docosatetraenamide, N-(2-hydroxyethyl)-, (all-Z)-
- CBNumber:
- CB8339388
- Molecular Formula:
- C24H41NO2
- Molecular Weight:
- 375.59
- MDL Number:
- MFCD09878239
- MOL File:
- 150314-35-5.mol
- MSDS File:
- SDS
- TDS File:
- TDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS02,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H350 | |||||||||
| Precautionary statements | P201-P202-P210-P233-P240-P241-P242-P243-P280-P303+P361+P353-P308+P313-P370+P378-P403+P235-P405-P501 | |||||||||
| NFPA 704 |
|
DEA price More Price(10)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 90385 | Docosatetraenoyl Ethanolamide ≥98% | 150314-35-5 | 5mg | $75 | 2026-04-30 | Buy |
| Cayman Chemical | 90385 | Docosatetraenoyl Ethanolamide ≥98% | 150314-35-5 | 10mg | $143 | 2026-04-30 | Buy |
| Cayman Chemical | 90385 | Docosatetraenoyl Ethanolamide ≥98% | 150314-35-5 | 25mg | $333 | 2026-04-30 | Buy |
| Cayman Chemical | 90385 | Docosatetraenoyl Ethanolamide ≥98% | 150314-35-5 | 50mg | $589 | 2026-04-30 | Buy |
| ChemScene | CS-0032831 | Docosatetraenylethanolamide | 150314-35-5 | 25mg(66.56mM*1mLinEthanol) | $719 | 2026-06-04 | Buy |
DEA Chemical Properties, Uses, Production
Description
Docosatetraenoyl ethanolamide (DEA) is an endocannabinoid containing docosatetraenoic acid in place of the arachidonate moiety of AEA. DEA acts on CB1 receptors with potency and efficacy similar to that of AEA. However, its specific role and relative importance as a cannabinergic neurotransmitter have not been elucidated.
Uses
(7Z,10Z,13Z,16Z)-N-(2-Hydroxyethyl)-7,10,13,16-docosatetraenamide is an endocannabinoid and an analog of anandamide, which is an endogenous cannabinoid and TRPV1 receptor agonist.
Definition
ChEBI: 7,10,13,16-Docosatetraenoylethanolamine is a N-acylethanolamine 22:4.
Biological Activity
Potent endocannabinoid ( anandamide analog) that activates CB 1 receptors in microglia and binds to rat synaptosomal membranes (K I = 34.4 nM). Cannabimimetic in vivo .
IC 50
CB1
References
[1] LUMIR HANUS. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor[J]. Journal of Medicinal Chemistry, 1993, 36 20: 3032-3034. DOI: 10.1021/jm00072a026
DEA Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| EMMX Biotechnology LLC | 888-539-0666 | info@emmx.com | United States | 8435 | 60 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Tianjin Kailiqi Biotechnology Co., Ltd. | 15076683720 | klq@cw-bio.com | China | 9781 | 55 |
| Jinan Yaoyan Pharmaceutical Co., Ltd. | jnyaoyan@163.com | China | 3057 | 58 | |
| Nanjing Meihao Pharmaceutical Technology Co., Ltd. | meitaochem@126.com | meitaochem@126.com | China | 19087 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| Energy Chemical | 400-0056266 | marketing1@energy-chemical.com | China | 44927 | 58 |
| JinOu Biomedical (Nanjing) Co., Ltd. | 13000000000 | jinoupharma@163.com | China | 11706 | 58 |
150314-35-5 (DEA) Related Search:
1of4
